Literature DB >> 12842082

Targeting the TGF beta signaling network in human neoplasia.

Nancy Dumont1, Carlos L Arteaga.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12842082     DOI： 10.1016/s1535-6108(03)00135-1

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


× No keyword cloud information.
  79 in total

Review 1.  Role of TLR2-dependent inflammation in metastatic progression.

Authors:  Sunhwa Kim; Michael Karin
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

2.  A functional study of transforming growth factor-beta from the gonad of Pacific oyster Crassostrea gigas.

Authors:  Charlotte Corporeau; Agnès Groisillier; Alexandra Jeudy; Tristan Barbeyron; Elodie Fleury; Caroline Fabioux; Mirjam Czjzek; Arnaud Huvet
Journal:  Mar Biotechnol (NY)       Date:  2011-01-27       Impact factor: 3.619

3.  A combination of a transforming growth factor-beta antagonist and an inhibitor of cyclooxygenase is an effective treatment for murine pulmonary tuberculosis.

Authors:  R Hernández-Pando; H Orozco-Esteves; H A Maldonado; D Aguilar-León; M M Vilchis-Landeros; D A Mata-Espinosa; V Mendoza; F López-Casillas
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

4.  TGF-beta regulates the mechanical properties and composition of bone matrix.

Authors:  Guive Balooch; Mehdi Balooch; Ravi K Nalla; Stephen Schilling; Ellen H Filvaroff; Grayson W Marshall; Sally J Marshall; Robert O Ritchie; Rik Derynck; Tamara Alliston
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-14       Impact factor: 11.205

5.  Development of tumor-infiltrating CD8+ T cell memory precursor effector cells and antimelanoma memory responses are the result of vaccination and TGF-β blockade during the perioperative period of tumor resection.

Authors:  Emily C Bellavance; Frederick J Kohlhapp; Andrew Zloza; Jeremy A O'Sullivan; James McCracken; Michael C Jagoda; Andrew T Lacek; Mitchell C Posner; Jose A Guevara-Patino
Journal:  J Immunol       Date:  2011-02-02       Impact factor: 5.422

6.  A specific inhibitor of TGF-beta receptor kinase, SB-431542, as a potent antitumor agent for human cancers.

Authors:  Sunil K Halder; R Daniel Beauchamp; Pran K Datta
Journal:  Neoplasia       Date:  2005-05       Impact factor: 5.715

7.  New advances in breast cancer metastasis.

Authors:  Jose Russo; Hye-Jung Han; Yoshinori Kohwi; Terumi Kohwi-Shigematsu
Journal:  Womens Health (Lond)       Date:  2008-11

Review 8.  Targeting the transforming growth factor-beta signaling pathway in human cancer.

Authors:  Nagathihalli S Nagaraj; Pran K Datta
Journal:  Expert Opin Investig Drugs       Date:  2010-01       Impact factor: 6.206

9.  Transforming growth factor beta induces clustering of HER2 and integrins by activating Src-focal adhesion kinase and receptor association to the cytoskeleton.

Authors:  Shizhen Emily Wang; Bin Xiang; Roy Zent; Vito Quaranta; Ambra Pozzi; Carlos L Arteaga
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

Review 10.  The TGFBeta pathway as a therapeutic target in cancer.

Authors:  J Seoane
Journal:  Clin Transl Oncol       Date:  2008-01       Impact factor: 3.405
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.